13F-HR filed by FCPM III SERVICES B.V.
FCPM III SERVICES B.V. filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 10 holding rows worth $762,886,865.
- Accession
- 0001193125-26-053151
- Filer
- CIK 2013410
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 14 entries on the cover page, a total value of $762,886,865 stated on the cover page (in dollars after the unit check, H1), rows summing to $762,886,865 with VALUE read as dollars as filed, 13F file number 028-24008. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerForbion Growth Management B.V. 028-24009
- included managerForbion IV Management B.V. 028-24010
- included managerForbion Growth Management III B.V.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 9,198,900 | $322,697,412 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 5,462,846 | $106,853,268 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 9,632,561 | $86,982,026 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 1,833,333 | $62,094,989 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 3,226,400 | $56,671,716 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 3,617,354 | $47,314,990 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 2,808,368 | $27,297,337 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 3,468,430 | $24,556,484 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 1,677,852 | $19,899,325 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M113 | W EXP 10/31/2028 | 2,878,148 | $8,519,318 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-053151 | this filing | 2026-02-17 | acceptance time not in the bulk data set |